If you need more lookups,
subscriptions start at $34 USD/month.
Michelle Hall Location
United States
Michelle Hall Work
Co-Founder and General Partner, Entrée Bio @ (October 2025 - Present)
Associate Vice President @ Eli Lilly and Company (March 2022 - September 2025)
Senior Director, Genetic Medicine @ Eli Lilly and Company (December 2021 - March 2022)
Senior Director, New Therapeutic Modalities @ Eli Lilly and Company (September 2020 - December 2021)
Director of RNA Innovation @ Eli Lilly and Company (April 2020 - September 2020)
Past Chair @ (January 2020 - December 2020)
Chair @ (January 2019 - December 2019)
Chair Elect @ (January 2018 - December 2018)
Principal Scientist @ (March 2019 - April 2020)
Senior Scientist @ (May 2016 - March 2019)
Principal Scientist @ (January 2015 - January 2016)
Associate Principal Scientist @ (January 2013 - January 2015)
Senior Scientist @ (January 2012 - January 2013)
Postdoctoral Associate @ (January 2011 - January 2012)
Postdoctoral Associate @ (January 2011 - January 2012)
Graduate Research Assistant @ (September 2006 - September 2011)
Summer Intern @ (May 2006 - August 2006)
Undergraduate Research Assistant @ (May 2004 - May 2006)
Summer Intern @ (May 2005 - August 2005)
Michelle Hall Education
Columbia University
Ph.D (Chemistry)
2010-2011
Columbia University
M.Phil (Chemistry)
2007-2010
Columbia University
M.A (Chemistry)
2006-2007
The University of Texas at Austin
B.S. Summa Cum Laude (Chemistry)
2002-2006
Michelle Hall Summary
Michelle Hall, based in United States, is currently a Co-Founder and General Partner, Entrée Bio at Entrée Capital. Michelle Hall brings experience from previous roles at Eli Lilly and Company. Michelle Hall holds a 2010 - 2011 Ph.D in Chemistry @ Columbia University. Michelle Hall has 1 emails and 5 mobile phone numbers on RocketReach.
Looking for a different Michelle Hall?
Find contact details for 700 million professionals.